Great-West Lifeco Inc
GRWLFOTCFinancial Services● Active
$15.45
$-2.55(-14.17%)
Market Cap$35.5B
P/E Ratio—
52W High$18
52W Low$14.2014
Great-West Lifeco Inc (GRWLF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GRWLF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
$0.98
Est. $0.94 · +4.9%
Revenue
$5.54B
Est. $1.07B · +420.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 2-Quarter EPS Beat Streak
GRWLF reports quarterly as a OTC-listed Insurance - Life company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.03
Rev. $1.54B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.03
Rev. Est.$1.54B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 28, 2026 | $0.98 | — | — | — | $1.10B | — |
| ▲ Q2 FY2026 | May 6, 2026 | $0.94 | $0.98 | +4.9% | $5.54B | $1.07B | +420.4% |
| ▲ Q1 FY2026 | Feb 11, 2026 | $0.94 | $0.99 | +5.1% | $0.94B | $1.11B | -14.9% |
| ▼ Q3 FY2025 | Aug 5, 2025 | $0.86 | $0.73 | -15.6% | $4.37B | — | — |
| ▼ Q2 FY2025 | May 7, 2025 | $0.79 | $0.67 | -15.5% | — | — | — |
| ▲ Q1 FY2025 | Feb 5, 2025 | $0.79 | $0.85 | +7.8% | $-0.67B | — | — |
| ▼ Q4 FY2024 | Nov 6, 2024 | $0.79 | $0.70 | -11.3% | $7.84B | — | — |
| ▲ Q3 FY2024 | Aug 6, 2024 | $0.76 | $0.81 | +6.6% | $5.64B | — | — |
Q3 FY2026
Jul 28, 2026
EPS Actual
—
EPS Est.
$0.98
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Beat
EPS Actual
$0.98
EPS Est.
$0.94
EPS Surpr.
+4.9%
Revenue
$5.54B
Q1 FY2026
Feb 11, 2026Beat
EPS Actual
$0.99
EPS Est.
$0.94
EPS Surpr.
+5.1%
Revenue
$0.94B
Q3 FY2025
Aug 5, 2025Miss
EPS Actual
$0.73
EPS Est.
$0.86
EPS Surpr.
-15.6%
Revenue
$4.37B
Q2 FY2025
May 7, 2025Miss
EPS Actual
$0.67
EPS Est.
$0.79
EPS Surpr.
-15.5%
Revenue
—
Q1 FY2025
Feb 5, 2025Beat
EPS Actual
$0.85
EPS Est.
$0.79
EPS Surpr.
+7.8%
Revenue
$-0.67B
Q4 FY2024
Nov 6, 2024Miss
EPS Actual
$0.70
EPS Est.
$0.79
EPS Surpr.
-11.3%
Revenue
$7.84B
Q3 FY2024
Aug 6, 2024Beat
EPS Actual
$0.81
EPS Est.
$0.76
EPS Surpr.
+6.6%
Revenue
$5.64B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.87 | $1.87 | $1.87 | 1 |
| Q3 FY2028 | $1.75 | $1.75 | $1.75 | 1 |
| Q2 FY2028 | $1.73 | $1.73 | $1.73 | 1 |
| Q1 FY2028 | $1.65 | $1.65 | $1.65 | 1 |
| Q4 FY2027 | $1.57 | $1.57 | $1.57 | 1 |
| Q3 FY2027 | $1.54 | $1.54 | $1.54 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $2.0B | $2.0B | $2.0B | 1 |
| Q3 FY2028 | $1.9B | $1.9B | $1.9B | 1 |
| Q2 FY2028 | $1.9B | $1.9B | $1.9B | 1 |
| Q1 FY2028 | $1.8B | $1.8B | $1.8B | 1 |
| Q4 FY2027 | $1.8B | $1.8B | $1.8B | 1 |
| Q3 FY2027 | $1.7B | $1.7B | $1.7B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 6, 2026 | +4.9% | $18.00 | $18.00 | +0.00% |
| ▲ Q1 FY2026 | Feb 11, 2026 | +5.1% | $16.17 | $16.17 | +0.00% |
| ▼ Q3 FY2025 | Aug 5, 2025 | -15.6% | $15.45 | $15.45 | +0.00% |
| ▼ Q2 FY2025 | May 7, 2025 | -15.5% | $14.20 | $14.20 | +0.00% |
| ▲ Q1 FY2025 | Feb 5, 2025 | +7.8% | $14.29 | $14.29 | +0.00% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -11.3% | $15.50 | $15.50 | +0.00% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +6.6% | $14.06 | $14.06 | +0.00% |
| ▲ Q2 FY2024 | May 1, 2024 | +3.2% | $13.98 | $13.98 | +0.00% |
Q2 FY2026+0.00%
Report Date
May 6, 2026
EPS Beat/Miss
+4.9%
Price Before
$18.00
Price After
$18.00
Q1 FY2026+0.00%
Report Date
Feb 11, 2026
EPS Beat/Miss
+5.1%
Price Before
$16.17
Price After
$16.17
Q3 FY2025+0.00%
Report Date
Aug 5, 2025
EPS Beat/Miss
-15.6%
Price Before
$15.45
Price After
$15.45
Q2 FY2025+0.00%
Report Date
May 7, 2025
EPS Beat/Miss
-15.5%
Price Before
$14.20
Price After
$14.20
Q1 FY2025+0.00%
Report Date
Feb 5, 2025
EPS Beat/Miss
+7.8%
Price Before
$14.29
Price After
$14.29
Q4 FY2024+0.00%
Report Date
Nov 6, 2024
EPS Beat/Miss
-11.3%
Price Before
$15.50
Price After
$15.50
Q3 FY2024+0.00%
Report Date
Aug 6, 2024
EPS Beat/Miss
+6.6%
Price Before
$14.06
Price After
$14.06
Q2 FY2024+0.00%
Report Date
May 1, 2024
EPS Beat/Miss
+3.2%
Price Before
$13.98
Price After
$13.98
Avg Beat Reaction+0.00%
Avg Miss Reaction+0.00%
Beat Rate5 / 8 quarters
Largest Move+0.00% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GRWLF ends December
Great-West Lifeco Inc (GRWLF) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $0.98 — beating the analyst consensus of $0.94 by +4.9%. GRWLF has beaten EPS estimates for 2 consecutive quarters. The next GRWLF earnings date is expected around September 1, 2026.
Each quarter, investors track GRWLF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GRWLF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GRWLF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GRWLF earnings · 5 questionsGreat-West Lifeco Inc's next earnings report is expected around September 1, 2026. GRWLF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GRWLF historically reports after market close (AMC).
GRWLF earnings datewhen is GRWLF earningsGRWLF next earnings datewhen does GRWLF report earningsGRWLF earnings calendar
▸ Source: FMP · Great-West Lifeco Inc SEC filings · US GAAP · Great-West Lifeco Inc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026